Leading drug major Ranbaxy on Wednesday said it had drawn up an ambitious plan to spend nearly 200 million yen (over Rs. 10 crore) along with parent company Daiichi Sankyo over the next five years to sponsor mobile healthcare field clinics in India, Cameroon and Tanzania.
The services will be provided in basic healthcare, immunisation, maternal and child health services and health education over a five-year period, involving a total monetary contribution of nearly 200 million yen, according to a company statement.
The initiative will be implemented in India through the Ranbaxy Community Health Care Society and in Cameroon and Tanzania through an international NGO, Plan Japan, it said. “India is among the countries with the highest number of infant and maternal mortalities in the world and Cameroon and Tanzania have some of the highest infant mortality rates and maternal mortality ratios among developing countries in Africa,” it added.
This initiative will contribute directly in improving the lives and health of citizens who lack such access in the three countries, it added.
This is being done as part of the company's global social contribution activities and is in alignment with the United Nation's global ‘Millennium Development Goals' for reducing child mortality, improving maternal health and combating HIV/AIDS, malaria and other diseases, the statement added.
